Andrew A. F. Hack

Chief Financial Officer, Editas Medicine.

Companies

Mersana Therapeutics (United States)Board member Jun 27, 2017 to now¹
Nuvalent, Inc.Board member Jul 28, 2021 to Dec 13, 2024²
DYNAVAX TECHNOLOGIES CORPBoard member Aug 14, 2019 to Aug 10, 2023³
Allena Pharmaceuticals, Inc.Board member Jun 12, 2018 to Nov 18, 2020⁴
Atea Pharmaceuticals, Inc.Board member Oct 29, 2020 to Nov 3, 2020⁵
BCLS Acquisition Corp.Board member Oct 21, 2020 to Oct 26, 2020⁶
BCLS Acquisition Corp.Chief financial officer Oct 21, 2020 to Oct 26, 2020⁶
Editas MedicineChief financial officer Feb 2, 2016 to Feb 6, 2019⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

DYNAVAX TECHNOLOGIES CORP925,714 shares⁸Aug 10, 2023
Mersana Therapeutics (United States)0 shares⁹Jan 6, 2026
Nuvalent, Inc.1,449,766 shares¹⁰Dec 13, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 6, 2026U 346,545 shares of Mersana Therapeutics (United States)⁹
Jan 6, 2026U 578 shares of Mersana Therapeutics (United States)⁹
Dec 11, 2024Sold 1,250,000 shares at $88.00 of Nuvalent, Inc.¹⁰
Jun 12, 2024Granted 2,499 shares of Nuvalent, Inc.¹¹
Mar 27, 2024Sold 791,795 shares at $72.31 of Nuvalent, Inc.¹²
Mar 27, 2024Sold 88,205 shares at $76.88 of Nuvalent, Inc.¹²
Aug 8, 2023Sold 1,500,000 shares at $14.39 of DYNAVAX TECHNOLOGIES CORP⁸
Jun 14, 2023Sold 500,000 shares at $12.68 of DYNAVAX TECHNOLOGIES CORP¹³
Jun 8, 2023Granted 14,467 shares of Mersana Therapeutics (United States)¹⁴
May 26, 2023Granted 5,357 shares of DYNAVAX TECHNOLOGIES CORP¹⁵
May 18, 2023Sold 1,000,000 shares at $10.55 of DYNAVAX TECHNOLOGIES CORP¹⁶
Dec 6, 2022Sold 1,500,000 shares at $11.60 of DYNAVAX TECHNOLOGIES CORP¹⁷
Nov 3, 2022Bought 149,253 shares at $33.50 of Nuvalent, Inc.¹⁸
Aug 15, 2022Sold 3,000,000 shares at $14.68 of DYNAVAX TECHNOLOGIES CORP¹⁹
Jun 2, 2022Bought 14,760 shares at $3.20 of Mersana Therapeutics (United States)²⁰
May 31, 2022Bought 80,759 shares at $3.28 of Mersana Therapeutics (United States)²⁰
May 26, 2022Bought 75,000 shares at $3.19 of Mersana Therapeutics (United States)²¹
May 25, 2022Bought 90,155 shares at $3.18 of Mersana Therapeutics (United States)²¹
May 24, 2022Bought 100,000 shares at $3.29 of Mersana Therapeutics (United States)²¹
May 23, 2022Bought 15,599 shares at $3.35 of Mersana Therapeutics (United States)²²
May 20, 2022Bought 100,000 shares at $3.46 of Mersana Therapeutics (United States)²²
May 19, 2022Bought 100,000 shares at $3.49 of Mersana Therapeutics (United States)²²
May 18, 2022Bought 211,268 shares at $3.35 of Mersana Therapeutics (United States)²³
May 17, 2022Bought 3,440 shares at $3.18 of Mersana Therapeutics (United States)²³
May 16, 2022Bought 135,292 shares at $3.10 of Mersana Therapeutics (United States)²³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMersana Therapeutics (United States), Board member
2
SEC EDGARNuvalent, Inc., Board member
3
SEC EDGARDYNAVAX TECHNOLOGIES CORP, Board member
4
SEC EDGARAllena Pharmaceuticals, Inc., Board member
5
SEC EDGARAtea Pharmaceuticals, Inc., Board member
6
SEC EDGARBCLS Acquisition Corp., Board member
7
SEC EDGAREditas Medicine, Chief financial officer
8
SEC EDGARDYNAVAX TECHNOLOGIES CORP shares after the filing of Aug 10, 2023
9
SEC EDGARMersana Therapeutics (United States) shares after the filing of Jan 6, 2026
10
SEC EDGARNuvalent, Inc. shares after the filing of Dec 13, 2024
11
SEC EDGARForm 4 filed Jun 14, 2024
12
SEC EDGARForm 4 filed Mar 29, 2024
13
SEC EDGARForm 4 filed Jun 16, 2023
14
SEC EDGARForm 4 filed Jun 12, 2023
15
SEC EDGARForm 4 filed May 31, 2023
16
SEC EDGARForm 4 filed May 19, 2023
17
SEC EDGARForm 4 filed Dec 8, 2022
18
SEC EDGARForm 4 filed Nov 3, 2022
19
SEC EDGARForm 4 filed Aug 17, 2022
20
SEC EDGARForm 4 filed Jun 2, 2022
21
SEC EDGARForm 4 filed May 26, 2022
22
SEC EDGARForm 4 filed May 23, 2022
23
SEC EDGARForm 4 filed May 18, 2022